Skip to Content

Tag: Home Solutions


Also Noted

BioScrip, Home Solutions tweak deal

September 6, 2016HME News Staff

DENVER - The price tag for BioScrip's acquisition of Home Solutions has dropped from $85 million to $75 million, according to news reports. The cash component of the consideration has been dropped from $80 million to $67.5 million. To speed up the deal, the two companies have also agreed to eliminate the need for stockholder approval; instead, they have agreed to a shareholder meeting following the close of the deal to seek such approval and provide Home Solutions with certain contractual protections...

BioScrip, home infusion, Home Solutions, M&A


Read Full Articlered right arrow icon

Also Noted

BioScrip completes offering

June 22, 2016HME News Staff

DENVER - BioScrip has completed a public offering of common stock, netting approximately $83.15 million. The company will use the proceeds to fund the cash portion of its acquisition of HS Infusion Holdings; repay a portion of outstanding borrowings from its revolving credit facility; and for general corporate purposes, according to a press release. BioScrip announced earlier this month that it would acquire the Hammonton, N.J.-based Home Solutions for $85 million—$80 million of it in...

BioScrip, home infusion therapy, Home Solutions


Read Full Articlered right arrow icon

Specialty Providers

Greenleaf: 'Home infusion is a valuable option'

June 20, 2014Theresa Flaherty, Managing Editor

In his six years in the home infusion business, Dan Greenleaf has seen his share of challenges. Still, the new CEO of Home Solutions says it's an exciting place to be. He spoke with HME News recently about home infusion's role in the “medical neighborhood.”HME News: Why is this an exciting time for home infusion?Dan Greenleaf: We have a broken healthcare system in the sense that we are treating patients extremely inefficiently. The home is the preferred choice for the patient, for the...

Dan Greenleaf, home infusion, Home Solutions


Read Full Articlered right arrow icon

Also Noted

Former Apria exec moves to new post

December 2, 2013HME News Staff

DENVER - Daniel Greenleaf is now president and CEO of specialty-infusion company Home Solutions, the Denver Post reports. “His strong executive skills and commercial and operations background bring crucial elements to achieve significant growth, operational efficiencies and continued success for Home Solutions,” said Steve Neumann, managing partner of KRG Capital Partners. Greenleaf joined Apria as president of Coram Specialty Infusion in 2008, which CVS Caremark purchased last week...

apria, Coram, CVS, Daniel Greenleaf, Home Solutions


Read Full Articlered right arrow icon